Related Experiment Video
Updated: Aug 14, 2026

From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Central Diabetes Insipidus in a Patient With Lymphoma: A Case Report
Epameinondas Koumpis1, Lydia Kyriazopoulou1, Stelios Tigas2
1Department of Hematology, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina, GRC.
Abstract:
Primary central nervous system (CNS) lymphoma or systemic non-Hodgkin lymphoma that infiltrates the CNS can cause central diabetes insipidus (CDI). Polyuria and polydipsia should raise the suspicion of CDI development in patients with lymphoma that infiltrates the CNS. CDI is effectively treated with desmopressin. However, careful monitoring of the patient's serum sodium, fluid intake, urine output, and weight is necessary because patients receiving desmopressin may develop hyponatremia, so they should be alert to recognize this side effect promptly. Moreover, CDI due to lymphoma can occasionally be reversible. Therefore, the dosage of desmopressin should be adapted during or after the treatment of lymphoma.
More Related Videos
Related Concept Videos
Type I Diabetes III: Clinical Manifestations
Diabetic Nephropathy

